tiprankstipranks
Lakefront Biotherapeutics (LKFT)
NASDAQ:LKFT
US Market
LKFT
Lakefront Biotherapeutics
RESEARCH TOOLSreports
Want to see LKFT full AI Analyst Report?

Lakefront Biotherapeutics (LKFT) Income Statement

549 Followers

Lakefront Biotherapeutics Income Statement

Last quarter (Q1 2026), Lakefront Biotherapeutics's total revenue was €6.48M, a decrease of -91.36% from the same quarter last year. In Q1, Lakefront Biotherapeutics's net income was €14.49M. See Lakefront Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 1.11B€ 275.65M€ 239.72M€ 241.25M€ 484.85M
Gross Profit
€ 1.08B€ 240.79M€ 239.72M€ 241.25M€ 483.22M
Operating Expenses
€ 581.12M€ 429.12M€ 327.99M€ 372.31M€ 648.81M
Depreciation and Amortization
€ 55.88M€ 45.50M€ 43.64M€ 65.57M€ 21.30M
EBITDA
€ 358.96M€ 43.33M€ 51.04M€ 3.87M€ -100.93M
Operating Income
€ 501.39M€ -188.34M€ -88.26M€ -131.06M€ -165.60M
Other Income/Expenses
€ -200.52M€ 185.25M€ 93.89M€ 60.21M€ 48.57M
Pretax Income
€ 300.87M€ -3.08M€ 5.63M€ -70.85M€ -123.00M
Net Income
€ 320.88M€ 74.08M€ 211.70M€ -217.99M€ -125.42M
Per Share Metrics
Basic EPS
€ 4.87€ 1.12€ -0.06€ -3.32€ -1.91
Diluted EPS
€ 4.87€ 1.12€ -0.06€ -3.32€ -1.91
Weighted Average Shares Outstanding
 65.90M 66.14M 65.93M 65.70M 65.50M
Weighted Average Shares Outstanding (Diluted)
 65.90M 66.14M 65.93M 65.70M 65.50M
Currency in EUR

Lakefront Biotherapeutics Earnings and Revenue History